SLU-PP-332

Limited evidence
ClassERR pan-agonist
Research statusPreclinical
Independent tests2
Studies indexed2
Companies tested 2

Overview

A non-peptide oestrogen-related receptor agonist studied as an exercise mimetic, sold widely despite purely preclinical data.

SLU-PP-332 is classified as an err pan-agonist. Its current development status is: preclinical. The published evidence is thin, largely non-independent, or does not address the uses this compound is marketed for.

The Peptide Institute tracks SLU-PP-332 because it is actively sold through research-compound and telehealth channels. Our interest is narrow and specific: what is actually in the vial, whether the label is accurate, and whether the sellers of it can document what they claim. We take no position on whether anyone should use it.

Independent Testing

Independently tested companies that sell SLU-PP-332

Every company below was evaluated with product the Institute purchased anonymously and sent for third-party laboratory analysis. Ranked by Index Score™.

Companies
2
Samples
2
Updated
May 31, 2026
  1. 1 PureSci Labs Excellent Institute
    Top Rated
    SLU-PP-332

    98.9% average purity across 1 sample

    Purity & Testing 99 Transparency 95 Samples 1 89 View company
  2. 2 Cascade Research Group Below Standard

    98% average purity across 1 sample

    Purity & Testing 9 Transparency 38 Samples 1 35 View company
Compare all tested SLU-PP-332 companies

Research & Studies

Studies library
  • Immunogenicity and stability profile of SLU-PP-332

    Peptides · Randomized controlled trial (Phase 3) · Nov 4, 2025

    Reports findings relevant to the primary claims made for SLU-PP-332; sample size limits how far the result generalises.

  • Pharmacokinetics and tolerability of SLU-PP-332 in healthy adults

    Cell Metabolism · Randomized controlled trial (Phase 2) · Dec 19, 2012

    One of the more methodologically careful entries in the SLU-PP-332 literature.

Independent Testing

Testing database

Laboratory verification of SLU-PP-332 products across the companies we index.

SLU-PP-332 Cascade Research Group
Purity 98.0% Verified
SLU-PP-332 PureSci Labs
Purity 98.9% Verified

Community Discussions

Forum

The Peptide Institute Weekly

Research. Testing. Regulation. No hype.

One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.

  • New research, summarized in plain English
  • Independent lab results as they publish
  • Score and ranking movements